This inventor holds 1 USPTO granted patent. Top assignee: Sense Proteomic Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Jonathon Michael Blackburn: Innovator in Protein Array Technology
Introduction: Jonathon Michael Blackburn is a renowned inventor based in Cambridge, GB. He is particularly noted for his contributions to the field of biochemistry through his innovative work in developing methods for protein arrays. His advancements hold potential for significant applications in the biotechnological sector.
Latest Patents: Blackburn holds one patent entitled "Methods of making and using a protein array." This patent describes innovative methods for the preparation of protein arrays consisting of full-length proteins, and it also outlines their usage in various screening methods. This invention demonstrates Blackburn’s commitment to enhancing the efficiency and effectiveness of protein screening processes, which are crucial in biological research and drug development.
Career Highlights: Throughout his career, Jonathon has made substantial contributions through his work at Sense Proteomic Limited, a company that focuses on advancing proteomic technologies. His role at this institution showcases his ability to merge scientific research with practical applications, driving forward the boundaries of innovation in protein assays.
Collaborations: Jonathon has collaborated with several talented individuals during his career, including his coworkers John David Sutherland and Mitali Samaddar. Their collective efforts have further enriched the research environment within Sense Proteomic Limited and contributed to the successful implementation of innovative projects.
Conclusion: In summary, Jonathon Michael Blackburn is a pivotal figure in the development of protein array technologies. His patent contributions and collaborative efforts underscore his commitment to pushing the frontiers of scientific research, particularly within the realm of proteomics. As innovations like his continue to evolve, they promise to enhance our understanding of protein interactions and contribute to advancements in medical and biotechnological fields.